Profilo
Françoise Bono worked as a Senior Director-Strategic Development at OSE Immunotherapeutics SA from 2021 to 2023.
Prior to that, she was the Chief Scientific Officer at Valerio Therapeutics SA from 2017 to 2020.
She also served as the Executive Vice President-Oncology at Evotec (France) SAS in 2015 and 2016.
Dr. Bono holds a doctorate degree from Institut d'Administration Des Entreprises De Toulouse.
Precedenti posizioni note di Françoise Bono
| Società | Posizione | Fine |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | 02/12/2023 |
| VALERIO THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 01/11/2020 |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical and natural sciences | Corporate Officer/Principal | 01/11/2016 |
Formazione di Françoise Bono
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Valerio Therapeutics SA
Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Institut d'Administration Des Entreprises De Toulouse
Institut d'Administration Des Entreprises De Toulouse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical and natural sciences | Commercial Services |
















